Autonomous driving - Open Access .click

Results 161 to 170 of about 1,377,038 (265)

Autonomous Driving Open Road Complexity Classification. [PDF]

Sensors (Basel)
Yue H, Jia Y, Li T.
europepmc +1 more source

Epigenetic heterogeneity and plasticity in therapy‐induced tumor states through single‐cell multi‐omics

Molecular Oncology, EarlyView.
Single‐cell multi‐omics reveals epigenetic heterogeneity across therapy‐adaptive tumor states, including quiescent/dormant, drug‐tolerant persister, and EMT‐like phenotypes. By linking regulatory features with state‐associated biomarkers, these approaches inform biomarker‐guided therapeutic strategies for evolving tumors.
Hee Jung Kim, Hwiyeong Lee, Jin Hong, Daechan Park +3 more
wiley +1 more source

For Autonomous Driving: The LGAT Model—A Method for Long-Term Time Series Forecasting

Time series forecasting plays a critical role in a wide range of applications, including energy load forecasting, traffic flow management, weather prediction, and vision-based state prediction for autonomous driving. In the context of autonomous vehicles,
Guangle Song, Jiaqi Kang, Yufeng Sun, Guoyu Qi +3 more
core +1 more source

PAK1 activation drives divergent resistance mechanisms to aromatase inhibition and tamoxifen in a luminal: A breast cancer model

Molecular Oncology, EarlyView.
Breast cancer remains a major cause of cancer death in women, frequently developing endocrine therapy resistance. This study demonstrates that upregulated p21‐activated kinase 1 (PAK1) activity drives resistance to tamoxifen and long‐term estrogen deprivation in ER+ breast cancer models.
Luisa Schwarzmüller +10 more
wiley +1 more source

ARMOR: Pareto-Aware Dynamic Routing for Energy-Efficient Heterogeneous Multimodal Perception in Autonomous Driving. [PDF]

Ann N Y Acad Sci
Liu J, Zhang Y, Chen Y, Wang Y.
europepmc +1 more source

In vitro and in silico modelling of ROS1‐positive non‐small cell lung cancer reveals fusion‐dependent tyrosine kinase inhibitor responses

Molecular Oncology, EarlyView.
Drug resistance limits treatment success in a subset of lung cancers driven by ROS1 gene alterations. Using patient‐derived cells and computer simulations, we studied three key mutations and how they affect five targeted drugs. The mutations reduced drug effectiveness in different ways by altering protein structure and behavior.
Farhan Ul Haq +8 more
wiley +1 more source

An Interpretable and Edge Deployable Spatio-Temporal Trajectory Prediction for Autonomous Driving. [PDF]

Sensors (Basel)
Megalingam RK, Selvarajan NP, Vijay P.
europepmc +1 more source

Circulating microRNA signatures of cachexia and cancer in Canis familiaris as a comparative oncology model for human disease

Molecular Oncology, EarlyView.
Circulating microRNAs as biomarkers of cachexia and sex‐specific cancer in senior dogs. In 25 client‐owned dogs, four circulating miRNAs (miR‐15a, miR‐15b, miR‐16, miR‐140) were downregulated in cachexia, with miR‐16 the strongest individual biomarker (AUC = 0.899).
Soon‐Seok Park +6 more
wiley +1 more source

AutoMamba: Efficient Autonomous Driving Segmentation Model with Mamba. [PDF]

Sensors (Basel)
Sun H, Li Z, Zhu S.
europepmc +1 more source

Cancer‐associated mutations in endometriosis reframe a benign disease through molecular oncology

Molecular Oncology, EarlyView.
This review aims to comprehensively analyse cancer‐associated somatic mutations (CAMs) present in endometriotic lesions, emphasizing their biological roles, spatial distribution and implications for translational applications in medicine. By contextualizing a benign state within a genomic framework, this analysis seeks to establish its value as a ...
Clarissa Mujacic +15 more
wiley +1 more source

intelligent vehicles